In the News

This Week’s Top Headlines FDA Approves First Severe MS Treatment Posted 3/29/17 The FDA has approved the first treatment for severe multiple sclerosis. The decision came Tuesday after clinical trials showed positive results when treating patients with both...

Teva Offers EU Concessions Over Allergan Generics Deal

According to Reuters.com, “Teva Pharmaceutical Industries Ltd has offered concessions to allay EU antitrust concerns over its $40.5 billion bid for Allergan’s generics unit which will cement its position as the world’s largest generics...

ICYMI: Payers, Clearinghouses Say ICD-10 Going Well

According to a new article from Health Data Management, “Almost two weeks have passed since the ICD-10 mandate took effect and early results from major health insurers Humana and UnitedHealthcare are very encouraging.  Executives from both payers told the...

ICYMI: Could These Devices Someday Replace Drugs?

MDDIonline.com recently released an article outlining the latest devices that may someday overtake pharmaceutical drugs.  “The U.S. pharmaceutical market is roughly double the size of that for medical devices. Perhaps sensing an opportunity, some device firms...